Author: "Alhazzani W" / Database: OAIster - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Alhazzani W"' showing total 30 results

Start Over Author "Alhazzani W" Database OAIster

30 results on '"Alhazzani W"'

1. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline

Author: Møller, M, Alhazzani, W, Lewis, K, Belley-Cote, E, Granholm, A, Centofanti, J, Mcintyre, W, Spence, J, Al Duhailib, Z, Needham, D, Evans, L, Reintam Blaser, A, Pisani, M, D’Aragon, F, Shankar-Hari, M, Alshahrani, M, Citerio, G, Arora, R, Mehta, S, Girard, T, Ranzani, O, Hammond, N, Devlin, J, Shehabi, Y, Pandharipande, P, Ostermann, M, Møller, Morten H., Alhazzani, Waleed, Lewis, Kimberley, Belley-Cote, Emilie, Granholm, Anders, Centofanti, John, McIntyre, William B., Spence, Jessica, Al Duhailib, Zainab, Needham, Dale M., Evans, Laura, Reintam Blaser, Annika, Pisani, Margaret A., D’Aragon, Frederick, Shankar-Hari, Manu, Alshahrani, Mohammed, Citerio, Giuseppe, Arora, Rakesh C., Mehta, Sangeeta, Girard, Timothy D., Ranzani, Otavio T., Hammond, Naomi, Devlin, John W., Shehabi, Yahya, Pandharipande, Pratik, Ostermann, Marlies, Møller, M, Alhazzani, W, Lewis, K, Belley-Cote, E, Granholm, A, Centofanti, J, Mcintyre, W, Spence, J, Al Duhailib, Z, Needham, D, Evans, L, Reintam Blaser, A, Pisani, M, D’Aragon, F, Shankar-Hari, M, Alshahrani, M, Citerio, G, Arora, R, Mehta, S, Girard, T, Ranzani, O, Hammond, N, Devlin, J, Shehabi, Y, Pandharipande, P, Ostermann, M, Møller, Morten H., Alhazzani, Waleed, Lewis, Kimberley, Belley-Cote, Emilie, Granholm, Anders, Centofanti, John, McIntyre, William B., Spence, Jessica, Al Duhailib, Zainab, Needham, Dale M., Evans, Laura, Reintam Blaser, Annika, Pisani, Margaret A., D’Aragon, Frederick, Shankar-Hari, Manu, Alshahrani, Mohammed, Citerio, Giuseppe, Arora, Rakesh C., Mehta, Sangeeta, Girard, Timothy D., Ranzani, Otavio T., Hammond, Naomi, Devlin, John W., Shehabi, Yahya, Pandharipande, Pratik, and Ostermann, Marlies
Abstract: Purpose: The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM‐RPG) was to formulate evidence‐based guidance for the use of dexmedetomidine for sedation in invasively mechanically ventilated adults in the intensive care unit (ICU). Methods: We adhered to the methodology for trustworthy clinical practice guidelines, including use of the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence, and the Evidence-to-Decision framework to generate recommendations. The guideline panel comprised 28 international panelists, including content experts, ICU clinicians, methodologists, and patient representatives. Through teleconferences and web‐based discussions, the panel provided input on the balance and magnitude of the desirable and undesirable effects, the certainty of evidence, patients’ values and preferences, costs and resources, feasibility, acceptability, and research priorities. Results: The ICM‐RPG panel issued one weak recommendation (suggestion) based on overall moderate certainty of evidence: "In invasively mechanically ventilated adult ICU patients, we suggest using dexmedetomidine over other sedative agents, if the desirable effects including a reduction in delirium are valued over the undesirable effects including an increase in hypotension and bradycardia". Conclusion: This ICM-RPG provides updated evidence-based guidance on the use of dexmedetomidine for sedation in mechanically ventilated adults, and outlines uncertainties and research priorities.
Published: 2022

2. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Author: Evans, L, Rhodes, A, Alhazzani, W, Antonelli, M, Coopersmith, CM, French, C, Machado, FR, Mcintyre, L, Ostermann, M, Prescott, HC, Schorr, C, Simpson, S, Wiersinga, WJ, Alshamsi, F, Angus, DC, Arabi, Y, Azevedo, L, Beale, R, Beilman, G, Belley-Cote, E, Burry, L, Cecconi, M, Centofanti, J, Coz Yataco, A, De Waele, J, Dellinger, RP, Doi, K, Du, B, Estenssoro, E, Ferrer, R, Gomersall, C, Hodgson, C, Moller, MH, Iwashyna, T, Jacob, S, Kleinpell, R, Klompas, M, Koh, Y, Kumar, A, Kwizera, A, Lobo, S, Masur, H, McGloughlin, S, Mehta, S, Mehta, Y, Mer, M, Nunnally, M, Oczkowski, S, Osborn, T, Papathanassoglou, E, Perner, A, Puskarich, M, Roberts, J, Schweickert, W, Seckel, M, Sevransky, J, Sprung, CL, Welte, T, Zimmerman, J, Levy, M, Evans, L, Rhodes, A, Alhazzani, W, Antonelli, M, Coopersmith, CM, French, C, Machado, FR, Mcintyre, L, Ostermann, M, Prescott, HC, Schorr, C, Simpson, S, Wiersinga, WJ, Alshamsi, F, Angus, DC, Arabi, Y, Azevedo, L, Beale, R, Beilman, G, Belley-Cote, E, Burry, L, Cecconi, M, Centofanti, J, Coz Yataco, A, De Waele, J, Dellinger, RP, Doi, K, Du, B, Estenssoro, E, Ferrer, R, Gomersall, C, Hodgson, C, Moller, MH, Iwashyna, T, Jacob, S, Kleinpell, R, Klompas, M, Koh, Y, Kumar, A, Kwizera, A, Lobo, S, Masur, H, McGloughlin, S, Mehta, S, Mehta, Y, Mer, M, Nunnally, M, Oczkowski, S, Osborn, T, Papathanassoglou, E, Perner, A, Puskarich, M, Roberts, J, Schweickert, W, Seckel, M, Sevransky, J, Sprung, CL, Welte, T, Zimmerman, J, and Levy, M
Published: 2021

3. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update

Author: Alhazzani, W, Evans, L, Alshamsi, F, Møller, M, Ostermann, M, Prescott, H, Arabi, Y, Loeb, M, Ng Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Machado, F, Wunsch, H, Crowther, M, Cecconi, M, Koh, Y, Burry, L, Chertow, D, Szczeklik, W, Belley-Cote, E, Greco, M, Bala, M, Zarychanski, R, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Nainan Myatra, S, Arrington, A, Kleinpell, R, Citerio, G, Lewis, K, Bridges, E, Memish, Z, Hammond, N, Hayden, F, Alshahrani, M, Al Duhailib, Z, Martin, G, Kaplan, L, Coopersmith, C, Antonelli, M, Rhodes, A, Alhazzani, Waleed, Evans, Laura, Alshamsi, Fayez, Møller, Morten Hylander, Ostermann, Marlies, Prescott, Hallie C., Arabi, Yaseen M., Loeb, Mark, Ng Gong, Michelle, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Machado, Flavia, Wunsch, Hannah, Crowther, Mark, Cecconi, Maurizio, Koh, Younsuck, Burry, Lisa, Chertow, Daniel S., Szczeklik, Wojciech, Belley-Cote, Emilie, Greco, Massimiliano, Bala, Malgorzata, Zarychanski, Ryan, Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Nainan Myatra, Sheila, Arrington, Amy, Kleinpell, Ruth, Citerio, Giuseppe, Lewis, Kimberley, Bridges, Elizabeth, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Alshahrani, Muhammed, Al Duhailib, Zainab, Martin, Greg S., Kaplan, Lewis J., Coopersmith, Craig M., Antonelli, Massimo, Rhodes, Andrew, Alhazzani, W, Evans, L, Alshamsi, F, Møller, M, Ostermann, M, Prescott, H, Arabi, Y, Loeb, M, Ng Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Machado, F, Wunsch, H, Crowther, M, Cecconi, M, Koh, Y, Burry, L, Chertow, D, Szczeklik, W, Belley-Cote, E, Greco, M, Bala, M, Zarychanski, R, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Nainan Myatra, S, Arrington, A, Kleinpell, R, Citerio, G, Lewis, K, Bridges, E, Memish, Z, Hammond, N, Hayden, F, Alshahrani, M, Al Duhailib, Z, Martin, G, Kaplan, L, Coopersmith, C, Antonelli, M, Rhodes, A, Alhazzani, Waleed, Evans, Laura, Alshamsi, Fayez, Møller, Morten Hylander, Ostermann, Marlies, Prescott, Hallie C., Arabi, Yaseen M., Loeb, Mark, Ng Gong, Michelle, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Machado, Flavia, Wunsch, Hannah, Crowther, Mark, Cecconi, Maurizio, Koh, Younsuck, Burry, Lisa, Chertow, Daniel S., Szczeklik, Wojciech, Belley-Cote, Emilie, Greco, Massimiliano, Bala, Malgorzata, Zarychanski, Ryan, Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Nainan Myatra, Sheila, Arrington, Amy, Kleinpell, Ruth, Citerio, Giuseppe, Lewis, Kimberley, Bridges, Elizabeth, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Alshahrani, Muhammed, Al Duhailib, Zainab, Martin, Greg S., Kaplan, Lewis J., Coopersmith, Craig M., Antonelli, Massimo, and Rhodes, Andrew
Abstract: BACKGROUND: The coronavirus disease 2019 pandemic continues to affect millions worldwide. Given the rapidly growing evidence base, we implemented a living guideline model to provide guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU. METHODS: The Surviving Sepsis Campaign Coronavirus Disease 2019 panel has expanded to include 43 experts from 14 countries; all panel members completed an electronic conflict-of-interest disclosure form. In this update, the panel addressed nine questions relevant to managing severe or critical coronavirus disease 2019 in the ICU. We used the World Health Organization's definition of severe and critical coronavirus disease 2019. The systematic reviews team searched the literature for relevant evidence, aiming to identify systematic reviews and clinical trials. When appropriate, we performed a random-effects meta-analysis to summarize treatment effects. We assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach, then used the evidence-to-decision framework to generate recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. RESULTS: The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued nine statements (three new and six updated) related to ICU patients with severe or critical coronavirus disease 2019. For severe or critical coronavirus disease 2019, the panel strongly recommends using systemic corticosteroids and venous thromboprophylaxis but strongly recommends against using hydroxychloroquine. In addition, the panel suggests using dexamethasone (compared with other corticosteroids) and suggests against using convalescent plasma and therapeutic anticoagulation outside clinical trials. The Surviving Sepsis Campaign Coronavirus Diease 2019 panel suggests using remdesivir in nonventilated patients with severe coronavirus disease 2019 and suggests again
Published: 2021

4. Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 220775.pdf (Publisher’s version ) (Closed access)
Published: 2020

5. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Moller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Moller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 218601.pdf (Publisher’s version ) (Closed access), OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 52 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

6. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Author: Weiss, S.L., Peters, Mark J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, Mark J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: 1 februari 2020, Contains fulltext : 230013.pdf (Publisher’s version ) (Closed access), OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 49 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

7. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 220773.pdf (Publisher’s version ) (Closed access)
Published: 2020

8. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

Author: Weiss, SL, Peters, MJ, Alhazzani, W, Agus, MSD, Flori, HR, Inwald, DP, Nadel, S, Schlapbach, LJ, Tasker, RC, Argent, AC, Brierley, J, Carcillo, J, Carrol, ED, Carroll, CL, Cheifetz, IM, Choong, K, Cies, JJ, Cruz, AT, De Luca, D, Deep, A, Faust, SN, De Oliveira, CF, Hall, MW, Ishimine, P, Javouhey, E, Joosten, KFM, Joshi, P, Karam, O, Kneyber, MCJ, Lemson, J, MacLaren, G, Mehta, NM, Moller, MH, Newth, CJL, Nguyen, TC, Nishisaki, A, Nunnally, ME, Parker, MM, Paul, RM, Randolph, AG, Ranjit, S, Romer, LH, Scott, HF, Tume, LN, Verger, JT, Williams, EA, Wolf, J, Wong, HR, Zimmerman, JJ, Kissoon, N, Tissieres, P, Weiss, SL, Peters, MJ, Alhazzani, W, Agus, MSD, Flori, HR, Inwald, DP, Nadel, S, Schlapbach, LJ, Tasker, RC, Argent, AC, Brierley, J, Carcillo, J, Carrol, ED, Carroll, CL, Cheifetz, IM, Choong, K, Cies, JJ, Cruz, AT, De Luca, D, Deep, A, Faust, SN, De Oliveira, CF, Hall, MW, Ishimine, P, Javouhey, E, Joosten, KFM, Joshi, P, Karam, O, Kneyber, MCJ, Lemson, J, MacLaren, G, Mehta, NM, Moller, MH, Newth, CJL, Nguyen, TC, Nishisaki, A, Nunnally, ME, Parker, MM, Paul, RM, Randolph, AG, Ranjit, S, Romer, LH, Scott, HF, Tume, LN, Verger, JT, Williams, EA, Wolf, J, Wong, HR, Zimmerman, JJ, Kissoon, N, and Tissieres, P
Abstract: OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 49 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

9. Neuromuscular blockade in patients with ARDS: a rapid practice guideline

Author: Alhazzani, W, Belley-Cote, E, Moller, MH, Angus, DC, Papazian, L, Arabi, YM, Citerio, G, Connolly, B, Denehy, L, Fox-Robichaud, A, Hough, CL, Laake, JH, Machado, FR, Ostermann, M, Piraino, T, Sharif, S, Szczeklik, W, Young, PJ, Gouskos, A, Kiedrowski, K, Burns, KEA, Alhazzani, W, Belley-Cote, E, Moller, MH, Angus, DC, Papazian, L, Arabi, YM, Citerio, G, Connolly, B, Denehy, L, Fox-Robichaud, A, Hough, CL, Laake, JH, Machado, FR, Ostermann, M, Piraino, T, Sharif, S, Szczeklik, W, Young, PJ, Gouskos, A, Kiedrowski, K, and Burns, KEA
Abstract: The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM-RPG) is to formulate an evidence-based guidance for the use of neuromuscular blocking agents (NMBA) in adults with acute respiratory distress syndrome (ARDS). The panel comprised 20 international clinical experts from 12 countries, and 2 patient representatives. We adhered to the methodology for trustworthy clinical practice guidelines and followed a strict conflict of interest policy. We convened panelists through teleconferences and web-based discussions. Guideline experts from the guidelines in intensive care, development, and evaluation Group provided methodological support. Two content experts provided input and shared their expertise with the panel but did not participate in drafting the final recommendations. We followed the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence and grade recommendations and suggestions. We used the evidence to decision framework to generate recommendations. The panel provided input on guideline implementation and monitoring, and suggested future research priorities. The overall certainty in the evidence was low. The ICM-RPG panel issued one recommendation and two suggestions regarding the use of NMBAs in adults with ARDS. Current evidence does not support the early routine use of an NMBA infusion in adults with ARDS of any severity. It favours avoiding a continuous infusion of NMBA for patients who are ventilated using a lighter sedation strategy. However, for patients who require deep sedation to facilitate lung protective ventilation or prone positioning, and require neuromuscular blockade, an infusion of an NMBA for 48 h is a reasonable option.
Published: 2020

10. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Author: Weiss, S.L., Peters, Mark J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, Mark J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: 01 februari 2020, Contains fulltext : 230013.pdf (Publisher’s version ) (Closed access), OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 49 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

11. Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 220775.pdf (Publisher’s version ) (Closed access)
Published: 2020

12. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Moller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Moller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 218601.pdf (Publisher’s version ) (Closed access), OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 52 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

13. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 220773.pdf (Publisher’s version ) (Closed access)
Published: 2020

14. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 220773.pdf (Publisher’s version ) (Closed access)
Published: 2020

15. Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 220775.pdf (Publisher’s version ) (Closed access)
Published: 2020

16. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Author: Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Moller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, M.J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Moller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: Contains fulltext : 218601.pdf (Publisher’s version ) (Closed access), OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 52 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

17. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Author: Weiss, S.L., Peters, Mark J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., Tissieres, P., Weiss, S.L., Peters, Mark J., Alhazzani, W., Agus, M.S.D., Flori, H.R., Inwald, D.P., Nadel, S., Schlapbach, L.J., Tasker, R.C., Argent, A.C., Brierley, J., Carcillo, J., Carrol, E.D., Carroll, C.L., Cheifetz, I.M., Choong, K., Cies, J.J., Cruz, A.T., Luca, D. De, Deep, A., Faust, S.N., Oliveira, C.F. De, Hall, M.W., Ishimine, P., Javouhey, E., Joosten, K.F., Joshi, P., Karam, O., Kneyber, M.C.J., Lemson, J., MacLaren, G., Mehta, N.M., Møller, M.H., Newth, C.J., Nguyen, T.C., Nishisaki, A., Nunnally, M.E., Parker, M.M., Paul, R.M., Randolph, A.G., Ranjit, S., Romer, L.H., Scott, H.F., Tume, L.N., Verger, J.T., Williams, E.A., Wolf, J., Wong, H.R., Zimmerman, J.J., Kissoon, N., and Tissieres, P.
Abstract: 01 februari 2020, Contains fulltext : 230013.pdf (Publisher’s version ) (Closed access), OBJECTIVES: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 49 were weak recommendations, and nine were best-practice statements. For 13 questions, no rec
Published: 2020

18. Neuromuscular blockade in patients with ARDS: a rapid practice guideline

Author: Alhazzani, W, Belley-Cote, E, Møller, M, Angus, D, Papazian, L, Arabi, Y, Citerio, G, Connolly, B, Denehy, L, Fox-Robichaud, A, Hough, C, Laake, J, Machado, F, Ostermann, M, Piraino, T, Sharif, S, Szczeklik, W, Young, P, Gouskos, A, Kiedrowski, K, Burns, K, Alhazzani, Waleed, Belley-Cote, E., Møller, M. H., Angus, D. C., Papazian, L., Arabi, Y. M., Citerio, G., Connolly, B., Denehy, L., Fox-Robichaud, A., Hough, C. L., Laake, J. H., Machado, F. R., Ostermann, M., Piraino, T., Sharif, S., Szczeklik, W., Young, P. J., Gouskos, A., Kiedrowski, K., Burns, K. E. A., Alhazzani, W, Belley-Cote, E, Møller, M, Angus, D, Papazian, L, Arabi, Y, Citerio, G, Connolly, B, Denehy, L, Fox-Robichaud, A, Hough, C, Laake, J, Machado, F, Ostermann, M, Piraino, T, Sharif, S, Szczeklik, W, Young, P, Gouskos, A, Kiedrowski, K, Burns, K, Alhazzani, Waleed, Belley-Cote, E., Møller, M. H., Angus, D. C., Papazian, L., Arabi, Y. M., Citerio, G., Connolly, B., Denehy, L., Fox-Robichaud, A., Hough, C. L., Laake, J. H., Machado, F. R., Ostermann, M., Piraino, T., Sharif, S., Szczeklik, W., Young, P. J., Gouskos, A., Kiedrowski, K., and Burns, K. E. A.
Abstract: The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM-RPG) is to formulate an evidence-based guidance for the use of neuromuscular blocking agents (NMBA) in adults with acute respiratory distress syndrome (ARDS). The panel comprised 20 international clinical experts from 12 countries, and 2 patient representatives. We adhered to the methodology for trustworthy clinical practice guidelines and followed a strict conflict of interest policy. We convened panelists through teleconferences and web-based discussions. Guideline experts from the guidelines in intensive care, development, and evaluation Group provided methodological support. Two content experts provided input and shared their expertise with the panel but did not participate in drafting the final recommendations. We followed the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence and grade recommendations and suggestions. We used the evidence to decision framework to generate recommendations. The panel provided input on guideline implementation and monitoring, and suggested future research priorities. The overall certainty in the evidence was low. The ICM-RPG panel issued one recommendation and two suggestions regarding the use of NMBAs in adults with ARDS. Current evidence does not support the early routine use of an NMBA infusion in adults with ARDS of any severity. It favours avoiding a continuous infusion of NMBA for patients who are ventilated using a lighter sedation strategy. However, for patients who require deep sedation to facilitate lung protective ventilation or prone positioning, and require neuromuscular blockade, an infusion of an NMBA for 48 h is a reasonable option.
Published: 2020

19. Managing ICU surge during the COVID-19 crisis: rapid guidelines

Author: Aziz, S, Arabi, Y, Alhazzani, W, Evans, L, Citerio, G, Fischkoff, K, Salluh, J, Meyfroidt, G, Alshamsi, F, Oczkowski, S, Azoulay, E, Price, A, Burry, L, Dzierba, A, Benintende, A, Morgan, J, Grasselli, G, Rhodes, A, Møller, M, Chu, L, Schwedhelm, S, Lowe, J, Bin, D, Christian, M, Aziz, Shadman, Arabi, Yaseen M., Alhazzani, Waleed, Evans, Laura, Citerio, Giuseppe, Fischkoff, Katherine, Salluh, Jorge, Meyfroidt, Geert, Alshamsi, Fayez, Oczkowski, Simon, Azoulay, Elie, Price, Amy, Burry, Lisa, Dzierba, Amy, Benintende, Andrew, Morgan, Jill, Grasselli, Giacomo, Rhodes, Andrew, Møller, Morten H., Chu, Larry, Schwedhelm, Shelly, Lowe, John J., Bin, Du, Christian, Michael D., Aziz, S, Arabi, Y, Alhazzani, W, Evans, L, Citerio, G, Fischkoff, K, Salluh, J, Meyfroidt, G, Alshamsi, F, Oczkowski, S, Azoulay, E, Price, A, Burry, L, Dzierba, A, Benintende, A, Morgan, J, Grasselli, G, Rhodes, A, Møller, M, Chu, L, Schwedhelm, S, Lowe, J, Bin, D, Christian, M, Aziz, Shadman, Arabi, Yaseen M., Alhazzani, Waleed, Evans, Laura, Citerio, Giuseppe, Fischkoff, Katherine, Salluh, Jorge, Meyfroidt, Geert, Alshamsi, Fayez, Oczkowski, Simon, Azoulay, Elie, Price, Amy, Burry, Lisa, Dzierba, Amy, Benintende, Andrew, Morgan, Jill, Grasselli, Giacomo, Rhodes, Andrew, Møller, Morten H., Chu, Larry, Schwedhelm, Shelly, Lowe, John J., Bin, Du, and Christian, Michael D.
Abstract: Given the rapidly changing nature of COVID-19, clinicians and policy makers require urgent review and summary of the literature, and synthesis of evidence-based guidelines to inform practice. The WHO advocates for rapid reviews in these circumstances. The purpose of this rapid guideline is to provide recommendations on the organizational management of intensive care units caring for patients with COVID-19 including: planning a crisis surge response; crisis surge response strategies; triage, supporting families, and staff.
Published: 2020

20. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Author: Alhazzani, W, Møller, M, Arabi, Y, Loeb, M, Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Aboodi, M, Wunsch, H, Cecconi, M, Koh, Y, Chertow, D, Maitland, K, Alshamsi, F, Belley-Cote, E, Greco, M, Laundy, M, Morgan, J, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Alexander, P, Arrington, A, Centofanti, J, Citerio, G, Baw, B, Memish, Z, Hammond, N, Hayden, F, Evans, L, Rhodes, A, Alhazzani, Waleed, Møller, Morten Hylander, Arabi, Yaseen M., Loeb, Mark, Gong, Michelle Ng, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Aboodi, Michael, Wunsch, Hannah, Cecconi, Maurizio, Koh, Younsuck, Chertow, Daniel S., Maitland, Kathryn, Alshamsi, Fayez, Belley-Cote, Emilie, Greco, Massimiliano, Laundy, Matthew, Morgan, Jill S., Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Alexander, Paul E., Arrington, Amy, Centofanti, John E., Citerio, Giuseppe, Baw, Bandar, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Evans, Laura, Rhodes, Andrew, Alhazzani, W, Møller, M, Arabi, Y, Loeb, M, Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Aboodi, M, Wunsch, H, Cecconi, M, Koh, Y, Chertow, D, Maitland, K, Alshamsi, F, Belley-Cote, E, Greco, M, Laundy, M, Morgan, J, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Alexander, P, Arrington, A, Centofanti, J, Citerio, G, Baw, B, Memish, Z, Hammond, N, Hayden, F, Evans, L, Rhodes, A, Alhazzani, Waleed, Møller, Morten Hylander, Arabi, Yaseen M., Loeb, Mark, Gong, Michelle Ng, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Aboodi, Michael, Wunsch, Hannah, Cecconi, Maurizio, Koh, Younsuck, Chertow, Daniel S., Maitland, Kathryn, Alshamsi, Fayez, Belley-Cote, Emilie, Greco, Massimiliano, Laundy, Matthew, Morgan, Jill S., Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Alexander, Paul E., Arrington, Amy, Centofanti, John E., Citerio, Giuseppe, Baw, Bandar, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Evans, Laura, and Rhodes, Andrew
Abstract: Background: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed. Methods: We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant to the management of COVID-19 in the ICU. We searched the literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU. We identified relevant and recent systematic reviews on most questions relating to supportive care. We assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, then generated recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Recommendations were either strong or weak, or in the form of best practice recommendations. Results: The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which four are best practice statements, nine are strong recommendations, and 35 are weak recommendations. No recommendation was provided for six questions. The topics were: 1) infection control, 2) laboratory diagnosis and specimens, 3) hemodynamic support, 4) ventilatory support, and 5) COVID-19 therapy. Conclusion: The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new evidence in further releases of these guidelines.
Published: 2020

21. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Author: Alhazzani, W, Møller, M, Arabi, Y, Loeb, M, Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Aboodi, M, Wunsch, H, Cecconi, M, Koh, Y, Chertow, D, Maitland, K, Alshamsi, F, Belley-Cote, E, Greco, M, Laundy, M, Morgan, J, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Alexander, P, Arrington, A, Centofanti, J, Citerio, G, Baw, B, Memish, Z, Hammond, N, Hayden, F, Evans, L, Rhodes, A, Alhazzani, Waleed, Møller, Morten Hylander, Arabi, Yaseen M., Loeb, Mark, Gong, Michelle Ng, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Aboodi, Michael, Wunsch, Hannah, Cecconi, Maurizio, Koh, Younsuck, Chertow, Daniel S., Maitland, Kathryn, Alshamsi, Fayez, Belley-Cote, Emilie, Greco, Massimiliano, Laundy, Matthew, Morgan, Jill S., Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Alexander, Paul E., Arrington, Amy, Centofanti, John E., Citerio, Giuseppe, Baw, Bandar, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Evans, Laura, Rhodes, Andrew, Alhazzani, W, Møller, M, Arabi, Y, Loeb, M, Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Aboodi, M, Wunsch, H, Cecconi, M, Koh, Y, Chertow, D, Maitland, K, Alshamsi, F, Belley-Cote, E, Greco, M, Laundy, M, Morgan, J, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Alexander, P, Arrington, A, Centofanti, J, Citerio, G, Baw, B, Memish, Z, Hammond, N, Hayden, F, Evans, L, Rhodes, A, Alhazzani, Waleed, Møller, Morten Hylander, Arabi, Yaseen M., Loeb, Mark, Gong, Michelle Ng, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Aboodi, Michael, Wunsch, Hannah, Cecconi, Maurizio, Koh, Younsuck, Chertow, Daniel S., Maitland, Kathryn, Alshamsi, Fayez, Belley-Cote, Emilie, Greco, Massimiliano, Laundy, Matthew, Morgan, Jill S., Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Alexander, Paul E., Arrington, Amy, Centofanti, John E., Citerio, Giuseppe, Baw, Bandar, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Evans, Laura, and Rhodes, Andrew
Abstract: Background: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed. Methods: We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant to the management of COVID-19 in the ICU. We searched the literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU. We identified relevant and recent systematic reviews on most questions relating to supportive care. We assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, then generated recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Recommendations were either strong or weak, or in the form of best practice recommendations. Results: The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which 4 are best practice statements, 9 are strong recommendations, and 35 are weak recommendations. No recommendation was provided for 6 questions. The topics were: (1) infection control, (2) laboratory diagnosis and specimens, (3) hemodynamic support, (4) ventilatory support, and (5) COVID-19 therapy. Conclusion: The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new recommendations in further releases of these guidelines.
Published: 2020

22. Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future

Author: Alhazzani, W, Møller, M, Belley-Cote, E, Citerio, G, Alhazzani, Waleed, Møller, Morten Hylander, Belley-Cote, Emilie, Citerio, Giuseppe, Alhazzani, W, Møller, M, Belley-Cote, E, Citerio, G, Alhazzani, Waleed, Møller, Morten Hylander, Belley-Cote, Emilie, and Citerio, Giuseppe
Published: 2019

23. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

Author: Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M.H.W.A. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., Alhazzani, W., Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M.H.W.A. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., and Alhazzani, W.
Abstract: Item does not contain fulltext, OBJECTIVE: To update and expand the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the ICU. DESIGN: Thirty-two international experts, four methodologists, and four critical illness survivors met virtually at least monthly. All section groups gathered face-to-face at annual Society of Critical Care Medicine congresses; virtual connections included those unable to attend. A formal conflict of interest policy was developed a priori and enforced throughout the process. Teleconferences and electronic discussions among subgroups and whole panel were part of the guidelines' development. A general content review was completed face-to-face by all panel members in January 2017. METHODS: Content experts, methodologists, and ICU survivors were represented in each of the five sections of the guidelines: Pain, Agitation/sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption). Each section created Population, Intervention, Comparison, and Outcome, and nonactionable, descriptive questions based on perceived clinical relevance. The guideline group then voted their ranking, and patients prioritized their importance. For each Population, Intervention, Comparison, and Outcome question, sections searched the best available evidence, determined its quality, and formulated recommendations as "strong," "conditional," or "good" practice statements based on Grading of Recommendations Assessment, Development and Evaluation principles. In addition, evidence gaps and clinical caveats were explicitly identified. RESULTS: The Pain, Agitation/Sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption) panel issued 37 recommendations (three strong and 34 conditional), two good practice statements, and 32 ungraded, nonactionable statements. Three questions from the patient-centered prioritized question list remained without recommendation. CONCLUSIONS: We found substantial agreement amon
Published: 2018

24. Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

Author: Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., Alhazzani, W., Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., and Alhazzani, W.
Abstract: Item does not contain fulltext
Published: 2018

25. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials

Author: Alhazzani, W, Alshamsi, F, Belley-Cote, E, Heels-Ansdell, D, Brignardello-Petersen, R, Alquraini, M, Perner, A, Moller, MH, Krag, M, Almenawer, S, Rochwerg, B, Dionne, J, Jaeschke, R, Alshahrani, M, Deane, A, Perri, D, Thebane, L, Al-Omari, A, Finfer, S, Cook, D, Guyatt, G, Alhazzani, W, Alshamsi, F, Belley-Cote, E, Heels-Ansdell, D, Brignardello-Petersen, R, Alquraini, M, Perner, A, Moller, MH, Krag, M, Almenawer, S, Rochwerg, B, Dionne, J, Jaeschke, R, Alshahrani, M, Deane, A, Perri, D, Thebane, L, Al-Omari, A, Finfer, S, Cook, D, and Guyatt, G
Abstract: PURPOSE: Stress ulcer prophylaxis (SUP) is commonly prescribed in the intensive care unit. However, data from systematic reviews and conventional meta-analyses are limited by imprecision and restricted to direct comparisons. We conducted a network meta-analysis of randomized clinical trials (RCTs) to examine the safety and efficacy of drugs available for SUP in critically ill patients. METHODS: We searched MEDLINE, EMBASE, and the Cochrane Library Central Register of Controlled Trials through April 2017 for randomized controlled trials that examined the efficacy and safety of proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), and sucralfate for SUP in critically ill patients. No date or language restrictions were applied. Data on study characteristics, methods, outcomes, and risk of bias were abstracted by two reviewers. RESULTS: Of 96 potentially eligible studies, we included 57 trials enrolling 7293 patients. The results showed that PPIs are probably more effective for preventing clinically important gastrointestinal bleeding (CIB) than H2RAs [odds ratio (OR) 0.38; 95% confidence interval (95% CI) 0.20, 0.73], sucralfate (OR 0.30; 95% CI 0.13, 0.69), and placebo (OR 0.24; 95% CI 0.10, 0.60) (all moderate quality evidence). There were no convincing differences among H2RA, sucralfate, and placebo. PPIs probably increase the risk of developing pneumonia compared with H2RAs (OR 1.27; 95% CI 0.96, 1.68), sucralfate (OR 1.65; 95% CI 1.20, 2.27), and placebo (OR 1.52; 95% CI 0.95, 2.42) (all moderate quality). Mortality is probably similar across interventions (moderate quality). Estimates of baseline risks of bleeding varied significantly across studies, and only one study reported on Clostridium difficile infection. Definitions of pneumonia varied considerably. Most studies on sucralfate predate pneumonia prevention strategies. CONCLUSIONS: Our results provide moderate quality evidence that PPIs are the most effective agents in preventing CIB, but
Published: 2018

26. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

Author: Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M.H.W.A. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., Alhazzani, W., Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M.H.W.A. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., and Alhazzani, W.
Abstract: Item does not contain fulltext, OBJECTIVE: To update and expand the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the ICU. DESIGN: Thirty-two international experts, four methodologists, and four critical illness survivors met virtually at least monthly. All section groups gathered face-to-face at annual Society of Critical Care Medicine congresses; virtual connections included those unable to attend. A formal conflict of interest policy was developed a priori and enforced throughout the process. Teleconferences and electronic discussions among subgroups and whole panel were part of the guidelines' development. A general content review was completed face-to-face by all panel members in January 2017. METHODS: Content experts, methodologists, and ICU survivors were represented in each of the five sections of the guidelines: Pain, Agitation/sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption). Each section created Population, Intervention, Comparison, and Outcome, and nonactionable, descriptive questions based on perceived clinical relevance. The guideline group then voted their ranking, and patients prioritized their importance. For each Population, Intervention, Comparison, and Outcome question, sections searched the best available evidence, determined its quality, and formulated recommendations as "strong," "conditional," or "good" practice statements based on Grading of Recommendations Assessment, Development and Evaluation principles. In addition, evidence gaps and clinical caveats were explicitly identified. RESULTS: The Pain, Agitation/Sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption) panel issued 37 recommendations (three strong and 34 conditional), two good practice statements, and 32 ungraded, nonactionable statements. Three questions from the patient-centered prioritized question list remained without recommendation. CONCLUSIONS: We found substantial agreement amon
Published: 2018

27. Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

Author: Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., Alhazzani, W., Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J., Pandharipande, P.P., Watson, P.L., Weinhouse, G.L., Nunnally, M.E., Rochwerg, B., Balas, M.C., Boogaard, M. van den, Bosma, K.J., Brummel, N.E., Chanques, G., Denehy, L., Drouot, X., Fraser, G.L., Harris, J.E., Joffe, A.M., Kho, M.E., Kress, J.P., Lanphere, J.A., McKinley, S., Neufeld, K.J., Pisani, M.A., Payen, J.F., Pun, B.T., Puntillo, K.A., Riker, R.R., Robinson, B.R., Shehabi, Y., Szumita, P.M., Winkelman, C., Centofanti, J.E., Price, C., Nikayin, S., Misak, C.J., Flood, P.D., Kiedrowski, K., and Alhazzani, W.
Abstract: Item does not contain fulltext
Published: 2018

28. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach

Author: Zhang, Y, Coello, PA, Brozek, J, Wiercioch, W, Etxeandia-Ikobaltzeta, I, Akl, EA, Meerpohl, JJ, Alhazzani, W, Carrasco-Labra, A, Morgan, RL, Mustafa, RA, Riva, JJ, Moore, A, Yepes-Nuñez, JJ, Cuello-Garcia, C, AlRayees, Z, Manja, V, Falavigna, M, Neumann, I, Brignardello-Petersen, R, Santesso, N, Rochwerg, B, Darzi, A, Rojas, MX, Adi, Y, Bollig, C, Waziry, R, Schünemann, HJ, Zhang, Y, Coello, PA, Brozek, J, Wiercioch, W, Etxeandia-Ikobaltzeta, I, Akl, EA, Meerpohl, JJ, Alhazzani, W, Carrasco-Labra, A, Morgan, RL, Mustafa, RA, Riva, JJ, Moore, A, Yepes-Nuñez, JJ, Cuello-Garcia, C, AlRayees, Z, Manja, V, Falavigna, M, Neumann, I, Brignardello-Petersen, R, Santesso, N, Rochwerg, B, Darzi, A, Rojas, MX, Adi, Y, Bollig, C, Waziry, R, and Schünemann, HJ
Abstract: © 2017 The Author(s). Background: There are diverse opinions and confusion about defining and including patient values and preferences (i.e. the importance people place on the health outcomes) in the guideline development processes. This article aims to provide an overview of a process for systematically incorporating values and preferences in guideline development. Methods: In 2013 and 2014, we followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to adopt, adapt and develop 226 recommendations in 22 guidelines for the Ministry of Health of the Kingdom of Saudi Arabia. To collect context-specific values and preferences for each recommendation, we performed systematic reviews, asked clinical experts to provide feedback according to their clinical experience, and consulted patient representatives. Results: We found several types of studies addressing the importance of outcomes, including those reporting utilities, non-utility measures of health states based on structured questionnaires or scales, and qualitative studies. Guideline panels used the relative importance of outcomes based on values and preferences to weigh the balance of desirable and undesirable consequences of alternative intervention options. However, we found few studies addressing local values and preferences. Conclusions: Currently there are different but no firmly established processes for integrating patient values and preferences in healthcare decision-making of practice guideline development. With GRADE Evidence-to-Decision (EtD) frameworks, we provide an empirical strategy to find and incorporate values and preferences in guidelines by performing systematic reviews and eliciting information from guideline panel members and patient representatives. However, more research and practical guidance are needed on how to search for relevant studies and grey literature, assess the certainty of this evidence, and best summarize and present the findings.
Published: 2017

29. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines

Author: Blaser, AR, Starkopf, J, Alhazzani, W, Berger, MM, Casaer, MP, Deane, AM, Fruhwald, S, Hiesmayr, M, Ichai, C, Jakob, SM, Loudet, CI, Malbrain, MLNG, Gonzalez, JCM, Paugam-Burtz, C, Poeze, M, Preiser, J-C, Singer, P, Van Zanten, ARH, De Waele, J, Wendon, J, Wernerman, J, Whitehouse, T, Wilmer, A, Oudemans-van Straaten, HM, Blaser, AR, Starkopf, J, Alhazzani, W, Berger, MM, Casaer, MP, Deane, AM, Fruhwald, S, Hiesmayr, M, Ichai, C, Jakob, SM, Loudet, CI, Malbrain, MLNG, Gonzalez, JCM, Paugam-Burtz, C, Poeze, M, Preiser, J-C, Singer, P, Van Zanten, ARH, De Waele, J, Wendon, J, Wernerman, J, Whitehouse, T, Wilmer, A, and Oudemans-van Straaten, HM
Abstract: PURPOSE: To provide evidence-based guidelines for early enteral nutrition (EEN) during critical illness. METHODS: We aimed to compare EEN vs. early parenteral nutrition (PN) and vs. delayed EN. We defined "early" EN as EN started within 48 h independent of type or amount. We listed, a priori, conditions in which EN is often delayed, and performed systematic reviews in 24 such subtopics. If sufficient evidence was available, we performed meta-analyses; if not, we qualitatively summarized the evidence and based our recommendations on expert opinion. We used the GRADE approach for guideline development. The final recommendations were compiled via Delphi rounds. RESULTS: We formulated 17 recommendations favouring initiation of EEN and seven recommendations favouring delaying EN. We performed five meta-analyses: in unselected critically ill patients, and specifically in traumatic brain injury, severe acute pancreatitis, gastrointestinal (GI) surgery and abdominal trauma. EEN reduced infectious complications in unselected critically ill patients, in patients with severe acute pancreatitis, and after GI surgery. We did not detect any evidence of superiority for early PN or delayed EN over EEN. All recommendations are weak because of the low quality of evidence, with several based only on expert opinion. CONCLUSIONS: We suggest using EEN in the majority of critically ill under certain precautions. In the absence of evidence, we suggest delaying EN in critically ill patients with uncontrolled shock, uncontrolled hypoxaemia and acidosis, uncontrolled upper GI bleeding, gastric aspirate >500 ml/6 h, bowel ischaemia, bowel obstruction, abdominal compartment syndrome, and high-output fistula without distal feeding access.
Published: 2017

30. Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial

Author: Alhazzani, W, Guyatt, G, Marshall, JC, Hall, R, Muscedere, J, Lauzier, F, Thabane, L, Alshahrani, M, English, SW, Arabi, YM, Deane, AM, Karachi, T, Rochwerg, B, Finfer, S, Daneman, N, Zytaruk, N, Heel-Ansdell, D, Cook, D, Alhazzani, W, Guyatt, G, Marshall, JC, Hall, R, Muscedere, J, Lauzier, F, Thabane, L, Alshahrani, M, English, SW, Arabi, YM, Deane, AM, Karachi, T, Rochwerg, B, Finfer, S, Daneman, N, Zytaruk, N, Heel-Ansdell, D, and Cook, D
Abstract: INTRODUCTION: Clinicians routinely administer stress ulcer prophylaxis to mechanically ventilated patients in the intensive care unit (ICU), most commonly prescribing proton pump inhibitors (PPIs). However, the incidence of gastrointestinal (GI) bleeding from stress ulceration is low and recent observational studies suggest these agents may increase infections. Therefore, a large randomized clinical trial (RCT) is needed to inform modern practice. The aim of this multicenter pilot trial is to determine the feasibility of performing a large RCT to investigate the efficacy and safety of withholding intravenous pantoprazole. METHODS AND ANALYSIS: We will include adult critically ill patients who have an anticipated duration of ventilation of >=48 hours. We will exclude patients with acute or recent GI bleeding, pregnancy, dual antiplatelet therapy, poor prognosis or intent to withdraw life support, or previous enrolment in this or a confounding trial. Following informed consent, patients will be randomized to receive the intervention of placebo (0.9% NaCl) or intravenous pantoprazole 40 mg daily. Patients, families, clinicians, data collectors, adjudicators of outcome and statisticians will be blind to allocation. The three primary feasibility outcomes are the informed consent rate, recruitment rate, and protocol adherence. Clinical outcomes include clinically important upper GI bleeding, ventilator-associated pneumonia (VAP), Clostridium difficile infection, length of stay and mortality in ICU and hospital. ETHICS AND APPROVAL: This study has been approved by Health Canada, and research ethics board (REB) at each of the participating centers. TRIAL REGISTRATION NUMBER: This trial was registered on 31 October 2014. The trial registration number is NCT02290327. FUNDING: REVISE Pilot Trial is funded by Research Grant awarded by Physicians Services Incorporated, Dammam University Research Funds, Capital Health Authority Research Award Halifax, and Royal Adelaide Hospital
Published: 2016

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Refine your results

30 results on '"Alhazzani W"'

1. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline

2. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

3. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update

4. Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

5. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

6. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

7. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

8. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

9. Neuromuscular blockade in patients with ARDS: a rapid practice guideline

10. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

11. Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

12. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

13. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

14. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

15. Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

16. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

17. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

18. Neuromuscular blockade in patients with ARDS: a rapid practice guideline

19. Managing ICU surge during the COVID-19 crisis: rapid guidelines

20. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

21. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

22. Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future

23. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

24. Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

25. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials

26. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

27. Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

28. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach

29. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines

30. Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial

Catalog

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Publication Year Range

Publication Type

Database

Publisher

30 results on '"Alhazzani W"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources